These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1503453)

  • 1. In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents.
    Rolston KV; Nguyen HT; Ho DH; LeBlanc B; Bodey GP
    Antimicrob Agents Chemother; 1992 Apr; 36(4):879-82. PubMed ID: 1503453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics.
    Gu JW; Neu HC
    Antimicrob Agents Chemother; 1990 Feb; 34(2):189-95. PubMed ID: 2327765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents.
    Beskid G; Fallat V; Lipschitz ER; McGarry DH; Cleeland R; Chan K; Keith DD; Unowsky J
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1072-7. PubMed ID: 2782857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of Ro 23-9424, a dual-acting cephalosporin-quinolone antimicrobial agent.
    Qadri SM; Ueno Y; Saldin H; Cunha BA
    J Clin Pharmacol; 1993 Oct; 33(10):923-8. PubMed ID: 8227462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaxime.
    Jones RN; Barry AL; Thornsberry C
    Antimicrob Agents Chemother; 1989 Jun; 33(6):944-50. PubMed ID: 2504106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534.
    Jones RN; Sanchez ML
    Diagn Microbiol Infect Dis; 1994 Jan; 18(1):61-8. PubMed ID: 8026159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RO 23-9424, a new cephalosporin 3'-quinolone: in-vitro antimicrobial activity and tentative disc diffusion interpretive criteria.
    Pfaller MA; Barry AL; Fuchs PC
    J Antimicrob Chemother; 1993 Jan; 31(1):81-8. PubMed ID: 8444677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Brucella activity of Ro 23-9424, a dual-action antibacterial.
    Qadri SM; Ueno Y; Ayub A
    Chemotherapy; 1993; 39(6):386-9. PubMed ID: 8222864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS; Mazens-Sullivan MF; Bartlett RC
    Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of Ro 24-6778, a covalent bonding of desmethylfleroxacin and desacetylcefotaxime.
    Jones RN
    Diagn Microbiol Infect Dis; 1990; 13(3):253-9. PubMed ID: 2116952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients.
    Rolston K; Ho DH; LeBlanc B; Bodey GP
    Chemotherapy; 1988; 34(6):448-54. PubMed ID: 3149568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.
    Beskid G; Siebelist J; McGarry CM; Cleeland R; Chan K; Keith DD
    Chemotherapy; 1990; 36(2):109-16. PubMed ID: 2107064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.
    Barry AL; Fuchs PC
    Antimicrob Agents Chemother; 1991 May; 35(5):955-60. PubMed ID: 1906696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.
    Aldridge KE; Henderberg A; Gebbia K; Schiro DD; Janney A; Sanders CV
    Diagn Microbiol Infect Dis; 1989; 12(3):221-33. PubMed ID: 2791485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of the dual-action cephalosporin Ro 23-9424.
    Georgopapadakou NH; Bertasso A; Chan KK; Chapman JS; Cleeland R; Cummings LM; Dix BA; Keith DD
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1067-71. PubMed ID: 2675755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
    Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
    Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
    Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of T-3761, a new fluoroquinolone.
    Muratani T; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2293-303. PubMed ID: 1332594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of Ro 23-9424, ceftazidime, and eight other newer beta-lactams against 100 gram-positive blood culture isolates.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1989; 12(2):143-7. PubMed ID: 2666014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agents.
    Manek N; Andrews JM; Wise R
    Antimicrob Agents Chemother; 1986 Aug; 30(2):330-2. PubMed ID: 3094444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.